| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/23/2008 | EP1913016A1 Macrocyclic peptides as hcv ns3 protease inhibitors |
| 04/23/2008 | EP1272516B1 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 04/23/2008 | EP1144437B1 Transcription factor e2f dna-binding domain inhibitor peptides and their use |
| 04/23/2008 | CN100383161C Polypeptide for inhibiting gelatin enzyme A activity and its preparation method and application |
| 04/23/2008 | CN100383158C Method and compositions for peptide synthesis |
| 04/22/2008 | US7361731 Lithography; ink jet printing; for drug delivery |
| 04/22/2008 | US7361349 Immunocastration of pigs |
| 04/22/2008 | CA2261902C Radiolabeled annexin conjugates whith hexose and a chelator |
| 04/17/2008 | WO2008044890A1 A method for preparing peptides using by solid phase synthesis |
| 04/17/2008 | WO2008044794A1 Auxiliary reagent for gene transfer |
| 04/17/2008 | WO2008044599A1 Polypeptide having activity of targeting intestine having inflammation, and use thereof |
| 04/17/2008 | WO2008044567A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
| 04/17/2008 | WO2008022645A3 Ncam fibronectin type 3 binding peptides |
| 04/17/2008 | WO2008019888A3 Pax2 and pax8 as targets for immunologic and molecular tumour treatment strategies |
| 04/17/2008 | WO2006119388A8 Methods for the production of peptide having a c-terminal amide |
| 04/17/2008 | WO1999001471A9 Nik proteins, nucleic acids and methods |
| 04/17/2008 | US20080090771 Modification of pharmacokinetic and pharmacological properties of hydrocodone through covalent modification by conjugating hydrocodone with a carrier selected from an amino acid, a dipeptide, a tripeptide, a tetrapeptide and a pentapeptide; analgesic; bioavailability |
| 04/17/2008 | US20080090760 One or more individual peptide chains covalently linked to form dimers, homodimers heterodimers or multimers, optionally linked to linkers such as iminodiacetic acid, amino triacetate, goalpost 3, lysine amide, or modified by PEG; use for inhibiting angiogenesis and angiogenesis-related disease |
| 04/17/2008 | US20080090757 Particularly Kahalalide F, a tridecapeptide with a ring shape side and a lateral side amidated with 5-methylhexanoic acid; 650 mu g/m2/day administered intravenously in cycles of 1-4 weeks; photosensitizing agent selected from methoxsalen, methotrexate, etretinate,corticosteroid, cyclosporine; nontoxic |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080090260 Peptide sequence for use as substrate in bioassays which monitor aspartyl protease activity |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | US20080089900 Identification of self and non-self antigens implicated in autoimmune disease |
| 04/17/2008 | US20080089869 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 04/17/2008 | US20080089842 solid phase peptide synthesis for a peptidyl contrast agent; synthesizing an amino-chelator loaded resin coupling the loaded resin to C-terminus and/or backbone of a peptide, cleaving the amino-chelator-peptide from a resin, and chelating a lanthanide metal; DOTA or DTPA chelate coupled to peptide |
| 04/17/2008 | CA2665186A1 Stabilized therapeutic small helical antiviral peptides |
| 04/16/2008 | EP1911763A2 Compositions for the treatment of gastrointestinal disorders |
| 04/16/2008 | EP1910837A2 Methods and compositions for diagnosis and treatment of influenza |
| 04/16/2008 | EP1910406A2 Coloring compositions with peptide-based dispersants and binders |
| 04/16/2008 | EP1910405A2 Complement c3a derived peptides and uses thereof |
| 04/16/2008 | EP1909815A2 Novel biologically active peptides and their new uses |
| 04/16/2008 | EP1909813A2 Peptidyl diacylglycerides |
| 04/16/2008 | EP1551762A4 Peptide derivatives, and their use for the synthesis of silicon-based composite materials |
| 04/16/2008 | EP1309613B1 Pharmaceutical composition comprising an analgesic peptide |
| 04/16/2008 | EP0885244B2 Peptide immunogens for vaccination against and treatment of allergy |
| 04/16/2008 | CN101163799A 肽稳定剂化合物及筛选方法 Peptide stabilizer compounds and screening methods |
| 04/16/2008 | CN101163720A Rodent pest control |
| 04/16/2008 | CN101163713A Compound having amino acid residue or peptide residue and process for producing the same |
| 04/16/2008 | CN101161674A Cyclopeptide, preparation method and uses thereof |
| 04/16/2008 | CN100381461C Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 04/16/2008 | CN100381460C HER-2 analogue antigen epitope and peptide containing said epitope |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/15/2008 | US7358353 Expose cells to gene and nucleotide sequence that encodes T or B cell epitope; generates antibodies that bind specifically; immunogenic |
| 04/15/2008 | US7358342 Preparation derived from shark cartilage for treatment of diseased related to excessive PHF or excessive intracellular calcium |
| 04/15/2008 | US7358329 Antagonists to chaperonin 10 |
| 04/15/2008 | US7358230 Comprises antiproliferative peptides and/or polypeptides for treating tumors |
| 04/15/2008 | US7358229 Deuterated cyclosporin analogs and their use as immunomodulating agents |
| 04/15/2008 | US7358087 Adjuvant for enhancing immune response to preferential immunogen |
| 04/15/2008 | CA2323239C Novel matrix metalloproteinase inhibitors and down-regulators |
| 04/15/2008 | CA2269655C Peptide compositions with growth factor-like activity |
| 04/15/2008 | CA2114859C Cytotoxic and antiviral compound |
| 04/10/2008 | WO2008042686A2 Multifunctional carriers for the delivery of nucleic acids and methods of use thereof |
| 04/10/2008 | WO2008041693A1 Tool for screening of plant having useful trait and use thereof |
| 04/10/2008 | WO2008040986A1 Short peptidic neuropilin-1 antagonists and their use |
| 04/10/2008 | WO2008040833A1 Method for obtaining bicyclic peptides |
| 04/10/2008 | WO2008040536A1 Method for peptide synthesis |
| 04/10/2008 | WO2008040469A1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 04/10/2008 | WO2008040190A1 Small peptides for anti-angiogenesis and use thereof |
| 04/10/2008 | WO2008040111A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | WO2008023378A9 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| 04/10/2008 | WO2008003707A3 Minimized small peptides with high affinity for factor viii and factor viii-like proteins |
| 04/10/2008 | WO2007107587A3 Cholesterol lowering protein hydrolysates |
| 04/10/2008 | WO2007084715A3 Tat-031 and methods of assessing and treating cancer |
| 04/10/2008 | WO2007068240A3 Peptides interacting with alpha-helical coiled-coil structures and/or coiled-coil sequences, substances derived therefrom, and use thereof |
| 04/10/2008 | US20080085529 Fluorescence assay for kinase activity |
| 04/10/2008 | US20080085323 Promotes myoblast differentiation based on identification of cellular processes affected by prelamin A processing |
| 04/10/2008 | US20080085299 Peptides derived from colostrinin |
| 04/10/2008 | CA2665904A1 Peptides derived from the c2 domain of .epsilon.pkc and methods of use, thereof |
| 04/10/2008 | CA2665559A1 Method for peptide synthesis |
| 04/10/2008 | CA2665351A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | CA2665269A1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 04/09/2008 | EP1908781A2 Modulation of immune response and methods based thereon |
| 04/09/2008 | EP1908774A1 Antibacterial and antiviral peptides from Actinomadura namibiensis |
| 04/09/2008 | EP1908770A1 Methods for preparing purified lipopeptides |
| 04/09/2008 | EP1907413A2 Antibacterial amide macrocycles vii |
| 04/09/2008 | EP1907010A2 Peptides for use in the treatment of obesity |
| 04/09/2008 | EP1906988A2 Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 04/09/2008 | EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 04/09/2008 | CN101160319A Polymyxin b analogs for lps detoxification |
| 04/09/2008 | CN101160318A Compositions and methods for topical application and transdermal delivery of an oligopeptide |
| 04/09/2008 | CN101157924A Neutrophil leukocyte gene alpha |
| 04/09/2008 | CN101157720A Template fixed peptide analogue as serine protease inhibitor |
| 04/09/2008 | CN100379865C Method and reagents for vaccination which generate a CD8 T cell immune response |
| 04/09/2008 | CN100379760C Peptides and compounds that bind to receptor |
| 04/09/2008 | CN100379756C Polyamid-oligonucleotide derivative, preparation and application of same |
| 04/08/2008 | US7355019 Cysteine-containing peptide tag for site-specific conjugation of proteins |
| 04/08/2008 | US7354995 Magnetic substance-biosubstance complex structure, peptide fragment capable of linking to magnetic substance and gene therefor, and process for producing the complex structure |
| 04/08/2008 | US7354991 Heptapeptides having the natural binding site for autoantibodies found in elevated levels in schizophrenics binds to serum sample obtained from a schizophrenic patient at a substantively higher level than its binding to a body fluid sample obtained from a non-schizophrenic individual; diagnosis kits |
| 04/08/2008 | US7354756 Expression of nucleic acid produces polypeptide which spontaneously splices in host to yield a cyclized form; catalyzes formation of aminosuccinimide; useful in drug screening |
| 04/08/2008 | US7354737 peptide delivers biological response modifiers into cytoplasm, intracellular organelles or nucleus of prokaryotic/eukaryotic cells; use in drug delivery, vaccines, gene and protein therapy |
| 04/03/2008 | WO2008039483A2 Modified self-assembling peptides |
| 04/03/2008 | WO2008038766A1 Functional peptide having activity of stimulating immune cell |
| 04/03/2008 | WO2008018792A3 Cyclic angiotensin analogs |
| 04/03/2008 | WO2008013454A3 Immunogenic compounds and protein mimics |
| 04/03/2008 | WO2007127457A9 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
| 04/03/2008 | WO2007076302A3 High throughput assay for modulators of peptidylarginine deiminase activity |
| 04/03/2008 | US20080081901 Alpha-conotoxin peptides |
| 04/03/2008 | US20080081831 (3mercapta-1,2,4-triazole-5yl)-phenyl-tertbutane; cadherin cell adhesion recognition sequence His-Ala-Val within a cyclic peptide ring; enhance drug delivery to cells in need (tumor, Schwann cells, oligodendrocytes, graft rejection, epidermal patches); anticarcinogenic, angiogenesis inhibitor |
| 04/02/2008 | EP1905869A1 Three-dimensional structure of functional material |
| 04/02/2008 | EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |